Results 11 to 20 of about 607,096 (382)

A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition [PDF]

open access: yes, 2013
The membrane proximal external region (MPER) of the HIV-1 glycoprotein gp41 is targeted by the broadly neutralizing antibodies 2F5 and 4E10. To date, no immunization regimen in animals or humans has produced HIV-1 neutralizing MPER-specific antibodies ...
Aasa-Chapman, Marlén M. I.   +23 more
core   +23 more sources

BepiPred‐3.0: Improved B‐cell epitope prediction using protein language models

open access: yesbioRxiv, 2022
B-cell epitope prediction tools are of great medical and commercial interest due to their practical applications in vaccine development. The introduction of protein language models (LM) trained on unprecedented large datasets of protein sequences and ...
Joakim Clifford   +5 more
semanticscholar   +1 more source

Deep learning predictions of TCR-epitope interactions reveal epitope-specific chains in dual alpha T cells

open access: yesbioRxiv, 2023
T cells have the ability to eliminate infected and cancer cells and play an essential role in cancer immunotherapy. T-cell activation is elicited by the binding of the T-cell receptor (TCR) to epitopes displayed on MHC molecules, and the TCR specificity ...
Giancarlo Croce   +6 more
semanticscholar   +1 more source

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

open access: yesScience, 2020
Targeting the SARS-CoV-2 spike The surface of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) is decorated with trimeric spikes that bind to host cell receptors.
M. Yuan   +7 more
semanticscholar   +1 more source

Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

open access: yesScience, 2020
Profiling coronaviruses Among the coronaviruses that infect humans, four cause mild common colds, whereas three others, including the currently circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), result in severe infections.
Ellen Shrock   +45 more
semanticscholar   +1 more source

Broadly neutralizing antibodies target a haemagglutinin anchor epitope

open access: yesNature, 2021
Broadly neutralizing antibodies that target epitopes of haemagglutinin on the influenza virus have the potential to provide near universal protection against influenza virus infection1.
Jenna J. Guthmiller   +32 more
semanticscholar   +1 more source

Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach

open access: yesJournal of Medical Virology, 2020
Recently, a novel coronavirus (SARS‐COV‐2) emerged which is responsible for the recent outbreak in Wuhan, China. Genetically, it is closely related to SARS‐CoV and MERS‐CoV. The situation is getting worse and worse, therefore, there is an urgent need for
M. Bhattacharya   +7 more
semanticscholar   +1 more source

A candidate multi-epitope vaccine against SARS-CoV-2

open access: yesScientific Reports, 2020
In the past two decades, 7 coronaviruses have infected the human population, with two major outbreaks caused by SARS-CoV and MERS-CoV in the year 2002 and 2012, respectively.
Tamalika Kar   +6 more
semanticscholar   +1 more source

The Immune Epitope Database (IEDB): 2018 update

open access: yesNucleic Acids Res., 2018
The Immune Epitope Database (IEDB, iedb.org) captures experimental data confined in figures, text and tables of the scientific literature, making it freely available and easily searchable to the public. The scope of the IEDB extends across immune epitope
R. Vita   +8 more
semanticscholar   +1 more source

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

open access: yesJournal of Biomolecular Structure and Dynamics, 2020
At present, novel Coronavirus (2019-nCoV, the causative agent of COVID-19) has caused worldwide social and economic disruption. The disturbing statistics of this infection promoted us to develop an effective vaccine candidate against the COVID-19.
Maryam Enayatkhani   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy